This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Eisai Company, Limited, Eisai R&d Management Co., Ltd.. Active years: 2006-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2010
Title: Naohiro Kohmura: Innovator in 1H-Indazole Compounds
Introduction
Naohiro Kohmura is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on 1H-indazole compounds. With a total of 4 patents to his name, Kohmura's innovations have the potential to impact therapeutic applications.
Latest Patents
Kohmura's latest patents focus on a novel 1H-indazole compound that exhibits excellent JNK inhibitory action. The invention provides a compound represented by a specific formula, which includes various functional groups such as C-Caromatic cyclic hydrocarbon groups and C-Ccycloalkyl groups. This compound may serve as a valuable tool in the development of new therapeutic agents.
Career Highlights
Throughout his career, Naohiro Kohmura has worked with prominent organizations, including Eisai Company, Limited and Eisai R&D Management Co., Ltd. His experience in these companies has allowed him to refine his expertise in drug development and innovation.
Collaborations
Kohmura has collaborated with esteemed colleagues such as Norihito Ohi and Nobuaki Sato. These partnerships have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Naohiro Kohmura's work in the field of 1H-indazole compounds showcases his innovative spirit and dedication to advancing medicinal chemistry. His contributions are poised to make a significant impact in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile